<?xml version="1.0" encoding="UTF-8"?>
<p id="Par62">Finally, an earlier hypothesis illustrated that losartan as an angiotensin receptor 1 (AT1R) blocker in the RAS pathway could be useful for patients infected by COVID-19 who experience pneumonia [
 <xref ref-type="bibr" rid="CR66">66</xref>].
</p>
